PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects—A Phase 2 Clinical Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2024.08.008 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Simona F Shaitelman und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: sfshaitelman@mdanderson.org. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
PURPOSE: Radiation therapy is an underinvestigated tool for priming the immune system in intact human breast cancers. We sought here to investigate if a preoperative radiation therapy boost delivered was associated with a significant change in tumor-infiltrating lymphocytes (TILs) in the tumor in estrogen receptor positive, HER2Neu nonamplified breast cancers. METHODS AND MATERIALS: A total of 20 patients were enrolled in a phase 2 clinical trial and received either 7.5 Gy × 1 fraction or 2 Gy × 5 fractions, completed 6 to 8 days before surgery. Percent stromal TILs were evaluated on hematoxylin and eosin-stained samples. Short-term safety was assessed based on time to surgery, toxicities, and cosmesis up to 6 months after boost. RESULTS: Stromal TIL increased 6 to 8 days after completion of boost radiation therapy (median 3.0 [IQR, 1.0-6.5]) before radiation therapy versus median 5.0 (IQR, 1.5-8.0) after radiation therapy, P = .0037. Zero grade ≥3 toxicities up to 6 months after boost were experienced. In all, 94% (16/17) patients with 6-month follow-up cosmetic assessment after breast conservation had good-excellent cosmesis by physician assessment. CONCLUSION: In this phase 2 trial, preoperative radiation therapy boost resulted in a short-term increase in stromal TIL with minimal toxicities. Preoperative breast radiation therapy appears to be safe and may be a feasible means for priming the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: sfshaitelman@mdanderson.org.
- Department of Breast Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Genomics, University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Anatomical Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Förderung
- NCI NIH HHS
- National Cancer Institute
- University of Texas MD Anderson Cancer Center
Zitieren
APA
Shaitelman, S. F., Le-Petross, H., Raso, M. G., Swanson, D. M., Schalck, A. P., Contreras, A., Yang, F., Muruganandham, M., Zhao, G. Z., Sawakuchi, G. O., Kim, L. H., Batra, H., Smith, B. D., Stauder, M. C., Woodward, W. A., Reddy, J. P., Litton, J. K., Thompson, A., Bedrosian, I., & Mittendorf, E. A. (2025). PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects—A Phase 2 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.08.008
Vancouver
Shaitelman SF, Le-Petross H, Raso MG, Swanson DM, Schalck AP, Contreras A, et al. PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects—A Phase 2 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2024.08.008
BibTeX
@article{Shaitelman2025,
author = {Shaitelman, Simona F and Le-Petross, Huong and Raso, Maria G and Swanson, David M and Schalck, Aislyn P and Contreras, Alejandro and Yang, Fei and Muruganandham, Manickam and Zhao, George Z and Sawakuchi, Gabriel O and Kim, Leonard H and Batra, Harsh and Smith, Benjamin D and Stauder, Michael C and Woodward, Wendy A and Reddy, Jay P and Litton, Jennifer K and Thompson, Alastair and Bedrosian, Isabelle and Mittendorf, Elizabeth A},
title = {PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects—A Phase 2 Clinical Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2024.08.008}
}
EUVIMED